Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Hindsight is 2020: COVID-19 and Cancer Care

Access Activity

Overview / Abstract:

As the global COVID-19 pandemic enters its second year, advances in preventive measures and treatment approaches are now benefiting patients dealing with cancer. In turn, clinicians, cancer patients, and clinical practice have evolved to continue life-saving treatment.

Mia Levy, MD, PhD, System Vice President for Cancer Services at Rush System for Health, leads a discussion with Rush University Medical Center oncology, infectious disease, and critical care experts to hear real-world experiences and how they have adapted to caring for patients in the ever-changing environment.

Topics to benefit your care of cancer patients include:
• Updates on the management of immunocompromised patients
• Therapies to minimize disease severity and improve outcomes in hospitalized patients
• The application of antibody therapies
• Vaccine development updates

Expiration

Jan 25, 2022

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Respiratory Therapy CE

Format

Webinar / Webcast / Video

Credits / Hours

.5

Accreditation

ACCME and ANCC

Presenters / Authors / Faculty

Mia Levy, MD, PhD (Moderator)
The Sheba Foundation Director of the Cancer Center at Rush University Medical Center
System Vice President for Cancer Services
Rush System for Health
Chicago, IL

Philip Bonomi, MD, MS
Alice Pirie Wirtz Professor of Medicin
Rush Medical College
Chicago, IL

Michael Lin, MD, MPH
Associate Professor
Department of Internal Medicine, Division of Infectious Diseases
Hospital Epidemiologist
Rush University Medical Center
Chicago, IL

Mark Yoder, MD, MS
Associate Professor
Department of Internal Medicine
Medical Director, Medical Intensive Care Unit
Rush University Medical Center
Chicago, IL

Sponsors / Supporters / Grant Providers

Sponsored by Rush University Medical Center and the Academy for Continued Healthcare Learning (ACHL)

Supported by educational grants from AbbVie Inc., Astellas, AstraZeneca, Lilly, and Pfizer Inc.

Keywords / Search Terms

ACHL COVID-19, hematologic tumor, solid tumor, telemedicine, cancer, oncology, pathology, screening, infection, therapeutic tolerability, immunosuppression, therapeutic decision-making, prophylactic antiviral therapy, pulmonology, critical care, infectious disease, telehealth, radiology, respiratory, respiratory therapy, emergency medicine, testing, Rush University Medical Center, ACHL, Academy for Continued Healthcare Learning Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map